Adma Biologics reported $18.97M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Adma Biologics ADMA:US USD 18.97M 24.11M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Dynavax Technologies DVAX:US USD 106.34M 21.9M
Minerva Neurosciences NERV:US USD 5.21M 1.76M
Novavax NVAX:US USD 861.77M 192.88M
Omeros OMER:US USD 50.77M 13.33M
Takeda 4502:JP JPY 949.56B 51.69B